|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5575 | (2006.01) |
| A61K 31/5575 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 25/06 | (2018.01) | ||
| A61P 25/06 | (2006.01) |
| (11) | Number of the document | 3091985 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15735190.9 |
| Date of filing the European patent application | 2015-01-09 | |
| (97) | Date of publication of the European application | 2016-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/010771 |
| Date | 2015-01-09 |
| (87) | Number | WO 2015/106068 |
| Date | 2015-07-16 |
| (30) | Number | Date | Country code |
| 201461925676 P | 2014-01-10 | US |
| (72) |
BRATZLER, Robert, L. , US
WAND, Martin , US
RYCKMAN, Frederick , US
SHINGLETON, Bradford, J. , US
|
| (73) |
Manistee Therapeutics, Inc. ,
84 Barnes Hill Road, Concord, MA 01742-5601,
US
|
| (54) | PROSTANGLANDINS FOR TOPICAL USE IN THE TREATMENT OF MIGRAINES. |
| PROSTANGLANDINS FOR TOPICAL USE IN THE TREATMENT OF MIGRAINES. |